| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.7M | -33.9% | -55.6% |
| Cost of Revenue | $8.0M | -18.1% | -49.3% |
| Gross Profit | $4.6M | -50.5% | -63.5% |
| R&D Expense | $9.1M | -10.6% | +61.9% |
| SG&A Expense | $13.8M | -19.9% | +11.9% |
| Operating Income | -$21.1M | +10.5% | -53.4% |
| Interest Expense | $2K | -99.9% | -100.0% |
| Pre-tax Income | -$19.7M | -116.2% | -58.3% |
| Income Tax | -$2K | -100.1% | -104.5% |
| Net Income | -$19.7M | -116.5% | -57.7% |
| EPS (Basic) | -$0.61 | -116.1% | -22.0% |
| EPS (Diluted) | -$0.61 | -116.4% | -22.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.3M | -43.8% | -30.1% |
| Short-term Investments | $76.4M | -6.2% | +909.2% |
| Accounts Receivable | $5.8M | -22.4% | -36.6% |
| Current Assets | $113.0M | -14.6% | +94.2% |
| Total Assets | $224.3M | -6.4% | +0.0% |
| Current Liabilities | $59.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$55.6M | — | — |
| Capital Expenditures | $20.9M | — | — |
| Investing Cash Flow | $142.9M | — | — |
| Financing Cash Flow | -$75.3M | — | — |
| Free Cash Flow | -$76.4M | — | — |
| -58.7% |
| Total Liabilities | $91.1M | +0.9% | -52.9% |
| Stockholders' Equity | $133.1M | -10.8% | +331.7% |